Tty Biopharm Company LimitedTPEX: 4105

Announcement of Year 2022 Annual General Meeting

· Issued by Tty Biopharm Company Limited
Close
Today's Information

Provided by: TTY BIOPHARM COMPANY LIMITED
SEQ_NO 4 Date of announcement 2022/03/09 Time of announcement 21:26:12
Subject
 Announcement of Year 2022 Annual General Meeting
Date of events 2022/03/09 To which item it meets paragraph 17
Statement
1.Date of the board of directors resolution:2022/03/09
2.General shareholders' meeting date:2022/05/26
3.General shareholders' meeting location:
Building A, 2F., No. 19-10, Sanchong Rd., Nangang Dist., Taipei City, Taiwan
(International Convention Center of Nangang Software Park)
4.Shareholders meeting will be held by means of (physical shareholders
 meeting/ visual communication assisted shareholders meeting /
 visual communication shareholders meeting):Physical shareholders meeting
5.Cause for convening the meeting I.Reported matters:
(1)Year 2021 Business Report
(2)Audit Committee's Review Report on the year 2021 Financial Statements
(3)Report on Employee and Directors Remuneration in year 2021
6.Cause for convening the meeting II.Acknowledged matters:
(1)Year 2021 Business Report and Financial Statements
(2)Year 2021 Profit Distribution
7.Cause for convening the meeting III.Matters for Discussion:
(1)The Amendment of "Articles of Incorporation"
(2)The Amendment of "Procedures for Acquisition or Disposal of Assets"
8.Cause for convening the meeting IV.Election matters:None
9.Cause for convening the meeting V.Other Proposals:None
10.Cause for convening the meeting VI.Extemporary Motions:None
11.Book closure starting date:2022/03/28
12.Book closure ending date:2022/05/26
13.Any other matters that need to be specified:
A Shareholder holding 1% or more of the total number of issued shares may
submit a written proposal for discussion at a regular shareholders meeting.
To facilitate the process of the board of directors, please register the
documents to the company with the contact information and mark
"Proposal for discussion at a regular shareholders meeting" on the envelope
from 2022/03/21 to 2022/03/31 5:00p.m.. Recipient: Department of Finance,
3F., No.3-1, Park St., Nangang Dist., Taipei City, Taiwan.
Telephone: +886-2-2652-5999. Anything not covered by the aforementioned
statement shall be govern by Article 172-1 of the Company Act.

Earlier from Tty Biopharm

All Tty Biopharm news releases